Theratechnologies Inc. ( THTX) - Key Metrics
Stock symbol THTX is outdated, potentially delisted? Maybe it is available on other exchange?
THTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.36 | -$0.09 | $0.25 | $0.25 |
| 2025Q1 | $0.39 | $0 | -$0.20 | -$0.40 |
| 2024Q4 | $0.49 | -$0.15 | $0 | $0 |
| 2024Q3 | $0.44 | $0.06 | $0.09 | $0.09 |
| 2024Q2 | $0.45 | $0.02 | -$0.01 | -$0.04 |
THTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -7.31 |
| 2025Q1 | ? | 174.89 |
| 2024Q4 | ? | -1.98 |
| 2024Q3 | ? | 5.34 |
| 2024Q2 | ? | 15.68 |
THTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 9.50% | ? |
| 2025Q1 | -24.25% | ? |
| 2024Q4 | -0.36% | ? |
| 2024Q3 | 6.97% | ? |
| 2024Q2 | -2.89% | ? |
THTX
Price: $3.39
52 week price:
Earnings Per Share: -0.19 USD
P/E Ratio: -17.84
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 5200
Market Capitalization: 155.9 million